Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2009Retina

Rituximab for Intraocular Lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

SISujit IttyUniversity of Southern CaliforniaJPJosé S. PulidoThomas Jefferson University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Itty et al. (2009) studied this question.

synapsesocial.com/papers/6aa7dd2399cbff611ada09bfhttps://doi.org/10.1097/iae.0b013e318192f574
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma2002 · 5,632 citations
  2. 2Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD201994 · 1,948 citations
  3. 3Treatment of relapsed idiopathic thrombocytopenic purpura with the anti‐CD20 monoclonal antibody rituximab: a pilot study2002 · 121 citations
  4. 4The role of radiation therapy in the management of ocular reticulum cell sarcoma1980 · 140 citations
  5. 5Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma1997 · 251 citations